Filtered By:
Drug: Erbitux
Therapy: Radiation Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells
Conclusion: Targeting Ras and PI3K activity improves the outcome of irradiation in cetuximab-resistant HNSCC cell lines in vitro.
Source: Radiotherapy and Oncology - July 29, 2013 Category: Radiology Authors: Mohammad Saki, Mahmoud Toulany, H. Peter Rodemann Tags: Original Articles Source Type: research
